[Retracted] Efficacy and Safety of Peginterferon α-2a and Entecavir Tenofovir in the Treatment of Chronic Hepatitis B Genotype C

Figure 5

Types and distribution of adverse symptoms in the three groups: (a) Types of adverse symptoms. (b) Control group. (c) Tenofovir group. (d) Entecavir group.

(a)

(b)

(c)

(d)